Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00751296 · TERMINATED
Trial details
- NCT number
- NCT00751296
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.